Ur Metser

8.5k total citations · 1 hit paper
220 papers, 5.6k citations indexed

About

Ur Metser is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Ur Metser has authored 220 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Pulmonary and Respiratory Medicine, 110 papers in Radiology, Nuclear Medicine and Imaging and 55 papers in Oncology. Recurrent topics in Ur Metser's work include Radiomics and Machine Learning in Medical Imaging (51 papers), Medical Imaging Techniques and Applications (48 papers) and Prostate Cancer Treatment and Research (42 papers). Ur Metser is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (51 papers), Medical Imaging Techniques and Applications (48 papers) and Prostate Cancer Treatment and Research (42 papers). Ur Metser collaborates with scholars based in Canada, Israel and United States. Ur Metser's co-authors include Einat Even‐Sapir, Hedva Lerman, Gennady Lievshitz, Eyal Mishani, Ilan Leibovitch, Elka Miller, Gideon Flusser, Patrick Veit‐Haibach, Claudia Ortega and Dan Grisaru and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ur Metser

204 papers receiving 5.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.

2006 589 citations Einat Even‐Sapir, Ur Metser et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ur Metser	2.8k	2.2k	1.4k	1.3k	778	220	5.6k
Heather A. Jacene	3.3k 1.1×	1.8k 0.8×	699 0.5×	1.7k 1.3×	737 0.9×	152	5.6k
Atul B. Shinagare	1.2k 0.4×	2.3k 1.0×	1.4k 1.0×	1.4k 1.0×	499 0.6×	223	5.0k
Eric Rohren	2.2k 0.8×	1.6k 0.7×	885 0.7×	1.1k 0.8×	543 0.7×	132	4.4k
Jun Itami	1.8k 0.6×	3.1k 1.4×	1.2k 0.9×	1.1k 0.8×	657 0.8×	258	5.9k
Junting Zheng	2.4k 0.9×	2.7k 1.2×	692 0.5×	1.5k 1.1×	246 0.3×	158	5.4k
Andrew Quon	2.6k 0.9×	2.0k 0.9×	675 0.5×	1.4k 1.1×	580 0.7×	114	4.8k
Janet E. Husband	2.7k 0.9×	1.8k 0.8×	1.9k 1.4×	1.0k 0.8×	494 0.6×	150	5.4k
Anne Kiil Berthelsen	2.0k 0.7×	1.6k 0.7×	619 0.5×	1.4k 1.1×	1.3k 1.6×	91	4.8k
Paolo Castellucci	3.0k 1.1×	3.6k 1.6×	648 0.5×	1.3k 0.9×	694 0.9×	194	6.0k
Simon S. Lo	2.2k 0.8×	4.6k 2.1×	3.1k 2.3×	2.2k 1.7×	896 1.2×	356	9.4k

Countries citing papers authored by Ur Metser

Since Specialization

Citations

This map shows the geographic impact of Ur Metser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ur Metser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ur Metser more than expected).

Fields of papers citing papers by Ur Metser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ur Metser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ur Metser. The network helps show where Ur Metser may publish in the future.

Co-authorship network of co-authors of Ur Metser

This figure shows the co-authorship network connecting the top 25 collaborators of Ur Metser. A scholar is included among the top collaborators of Ur Metser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ur Metser. Ur Metser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Metser, Ur, Aruz Mesci, Rosanna Chan, et al.. (2025). [¹⁸F]-FDG PET/CT in the Initial Staging of Squamous Cell Cancer of the Anal Canal: Results of a Prospective Multicenter Registry. Journal of Nuclear Medicine. 66(4). 537–542.

Mirshahvalad, Seyed Ali, Mohsen Beheshti, Ur Metser, et al.. (2025). Theranostic: A Primer for Radiologists. Canadian Association of Radiologists Journal. 77(1). 202–211. 1 indexed citations

Mirshahvalad, Seyed Ali, Andrés Kohan, Claudia Ortega, et al.. (2025). Added prognostic value of baseline pre-infusion 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy. Scientific Reports. 15(1). 39540–39540.

Hinzpeter, Ricarda, Andrés Kohan, Seyed Ali Mirshahvalad, et al.. (2024). Predictive [18F]-FDG PET/CT-Based Radiogenomics Modelling of Driver Gene Mutations in Non-small Cell Lung Cancer. Academic Radiology. 31(12). 5314–5323. 9 indexed citations

Mirshahvalad, Seyed Ali, Adriano Basso Dias, Sangeet Ghai, et al.. (2024). Value of Dynamic Contrast-Enhanced MRI for Grade Group Prediction in Prostate Cancer: A Radiomics Pilot Study. Academic Radiology. 32(1). 250–259.

Karam, Irene, Eric Berthelet, Andrea McNiven, et al.. (2024). A Phase II Single Arm Trial of Elective Volume Adjusted De-Escalation Radiotherapy (EVADER) in Patients with Low-risk HPV-related Oropharyngeal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 120(2). S7–S8. 3 indexed citations

Metser, Ur, et al.. (2024). Dual Somatostatin Receptor/¹⁸F-FDG PET/CT Imaging in Patients with Well-Differentiated, Grade 2 and 3 Gastroenteropancreatic Neuroendocrine Tumors. Journal of Nuclear Medicine. 65(10). 1591–1596. 4 indexed citations

Bernardino, Rui, Katherine Lajkosz, Rashid K. Sayyid, et al.. (2024). Association of Free-to-Total PSA Ratio and¹⁸F-DCFPyL Prostate-Specific Membrane Antigen PET/CT Findings in Patients with Biochemical Recurrence After Radical Prostatectomy: A Prospective Single-Center Study. Journal of Nuclear Medicine. 65(11). 1731–1739.

Ortega, Claudia, Yael Eshet, Anca Prica, et al.. (2023). Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin’s Lymphoma. Cancers. 15(7). 2056–2056. 14 indexed citations

10.

Rotstein, Lorne, et al.. (2023). 18F-fluorocholine PET/MRI versus ultrasound and sestamibi for the localization of parathyroid adenomas. Langenbeck s Archives of Surgery. 408(1). 155–155. 9 indexed citations

11.

Tremblay, Samuel, Andrew Weickhardt, Ian D. Davis, et al.. (2023). Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial. Cancer Imaging. 23(1). 57–57. 1 indexed citations

12.

Sayyid, Rashid K., Rui Bernardino, Ricardo Leão, et al.. (2023). Mesorectal nodal metastasis with seminal vesicle invasion in biochemically recurrent prostate cancer. British Journal of Urology. 132(6). 664–670.

13.

Dias, Adriano Basso, Sangeet Ghai, Claudia Ortega, et al.. (2023). Impact of 18F-DCFPyL PET/MRI in Selecting Men With Low-/Intermediate-Risk Prostate Cancer for Focal Ablative Therapies. Clinical Nuclear Medicine. 48(10). e462–e467. 5 indexed citations

14.

Han, Kathy, Anthony Fyles, Jennifer Croke, et al.. (2022). A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer. Clinical Cancer Research. 28(24). 5263–5271. 20 indexed citations

15.

Chan, Michael, Ashley Farrell, Nayaar Islam, et al.. (2022). Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis. Radiology. 304(3). 566–579. 52 indexed citations

16.

Dmytriw, Adam A., Claudia Ortega, Reut Anconina, et al.. (2022). Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up. Cancers. 14(13). 3105–3105. 5 indexed citations

17.

Ortega, Claudia, Rebecca Wong, Patrick Veit‐Haibach, et al.. (2021). Quantitative ⁶⁸Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with ¹⁷⁷Lu-DOTATATE. Journal of Nuclear Medicine. 62(10). 1406–1414. 55 indexed citations

18.

Glicksman, Rachel, Ur Metser, John F. Valliant, et al.. (2020). [ ¹⁸ F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial. BMJ Open. 10(4). e035959–e035959. 6 indexed citations

19.

Haynes, Jennifer, Trevor D. McKee, Yadong Wang, et al.. (2018). Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer. Clinical Cancer Research. 24(9). 2116–2127. 17 indexed citations

20.

Metser, Ur, Elka Miller, Hedva Lerman, et al.. (2015). 18F-FDG PET/CT in the Evaluation of Adrenal Masses. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact